Do all patients with advanced N-stage nasopharyngeal carcinoma benefit from the addition of induction chemotherapy to concurrent chemoradiotherapy?

BACKGROUND: The aim of this study was to evaluate the benefits from the addition of induction chemotherapy (IC) to concurrent chemoradiotherapy (CCRT) in N2-3 nasopharyngeal carcinoma (NPC). METHODS: A total of 3089 patients with nonmetastatic NPC, staged as N2-3 were retrospectively reviewed. IC co...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Ji-Jin, Jin, Ya-Nan, Liu, Zhi-Gang, Liu, Qiao-Dan, Pei, Xiao-Feng, Zhou, Huai-Li, Zhang, Wang-Jian, Zhang, Fan, Lin, Li, Lawrence, Wayne R., Wang, Si-Yang, Ma, Jun, Zhou, Guan-Qun, Sun, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431774/
https://www.ncbi.nlm.nih.gov/pubmed/30923578
http://dx.doi.org/10.1177/1758835919833863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431774/
https://www.ncbi.nlm.nih.gov/pubmed/30923578
http://dx.doi.org/10.1177/1758835919833863

Ejemplares similares